Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Pfizer’s long-awaited Lyme vaccine fails to impress in study

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result ...
abc7NY

New Pfizer data suggests 3rd COVID vaccine dose 'strongly' boosts protection against delta variant

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
fox13now

Pfizer asks FDA to authorize boosters for older teenagers

Pfizer is asking the Food and Drug Administration (FDA) to expand booster shot eligibility to 16- and 17-year-olds “It is our hope to provide strong protection for as many people as possible, ...